New Report Published: “Reimbursement Pathways for Psychedelic Therapies Across Europe”

A new report, “Reimbursement Pathways for Psychedelic Therapies Across Europe”—funded by Norrsken Mind and co-authored by Martin Gisby and Floris Wolswijk—dives deep into one of the most pressing questions in psychedelic policy today: how do we ensure equitable, timely access to novel psychedelic treatments? The report examines how European healthcare systems currently fund innovative mental health […]